New CMO Preps Aggressive SARS-CoV-2 Global Testing and Education Agenda as Company Confirms Variant Detection Capabilities in High-Volume Testing System CALGARY, AB, June 10, 2021 /CNW/
FluroTest and SNC-Lavalin Sign MoU to Bring Saliva Sample-Based SARS-CoV-2 Testing Solution System to Market in Canada and Beyond CALGARY, AB and MONTRÉAL, May 13, 2021 /PRNewswire/ – FluroTech
Clinical Trial Progresses Across Six Clinical Site Locations Throughout the US CALGARY, AB, May 10, 2021 /CNW/ – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostics Systems (“FluroTest”
CALGARY, AB, May 4, 2021 /CNW/ – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and subsidiary FluroTest Diagnostics Systems (“FluroTest” or The Company), a first-mover in surge-scale rapid antigen testing for the detection
Former US Assistant Secretary for Health, Admiral Joxel Garcia, MD, joins FluroTest advisory board to support COVID-19 rapid antigen testing system for the masses. Surging
FluroTech Shareholders to Control 100% of Pandemic Defense Testing System CALGARY, Alberta, March 15, 2021 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”),
CALGARY, Alberta, March 04, 2021 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”),
CALGARY, Alberta, March 01, 2021 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture partner
CALGARY, Alberta, Feb. 19, 2021 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest,
CALGARY, Alberta, Feb. 16, 2021 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”),
New CMO Preps Aggressive SARS-CoV-2 Global Testing and Education Agenda as Company Confirms Variant Detection Capabilities in High-Volume Testing System CALGARY, AB, June 10, 2021 /CNW/
FluroTest and SNC-Lavalin Sign MoU to Bring Saliva Sample-Based SARS-CoV-2 Testing Solution System to Market in Canada and Beyond CALGARY, AB and MONTRÉAL, May 13, 2021 /PRNewswire/ – FluroTech
Clinical Trial Progresses Across Six Clinical Site Locations Throughout the US CALGARY, AB, May 10, 2021 /CNW/ – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostics Systems (“FluroTest”
CALGARY, AB, May 4, 2021 /CNW/ – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and subsidiary FluroTest Diagnostics Systems (“FluroTest” or The Company), a first-mover in surge-scale rapid antigen testing for the detection
